Zevra Therapeutics logo

Zevra Therapeutics

ZVRA | NASDAQ
Chart Builder DCF Calculator
$9.25
+$0.17 (+1.87%)
At close: Nov 16, 2026, 4:00 PM ET
$9.25
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
+1.87%

Rating

Updated: Nov 16, 2026
74.5
+2.0 pts
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #33/1021 (Top 3%)

Key Statistics

Market Data

Market Cap $550.42M
1D Range
8.92 9.79
52W Range
8.10 14.75

Valuation (TTM)

PE 7.71
PB 2.30
EV/EBITDA 5.16

Valuation (NTM)

Forward PE 7.21
Forward PEG 12.34
Price Target $24.00
Loading financial charts...

Profile

Zevra Therapeutics, Inc., founded in 2006 and based in Celebration, Florida, is a biopharmaceutical company dedicated to discovering and developing innovative treatments for rare diseases. The company...

Sector Healthcare
Industry Biotechnology
Employees 61
IPO Date Apr 16, 2015
Website zevra.com
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 3, 2026
EPS
$0.26
Beat +64.97%
REV
$37.76M
Beat +1.82%
Next Earnings
Mar 8, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
7
Consensus
Buy
Price Target
$22.00
Upside
+137.84%
Buy (7)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.